Self Sanitisation to Prevent Transmission with Dr. Nanoxa

1. Govt. Of India Certified Startup - DIPP60858 “ To leverage the power of Nanotechnology to reduce the risk of microbial transmission via surface contact” Improving the “Hygiene Quotient” of the world, for a bettertomorrow... • Protecting Surfaces, ImpactingLives... • Global Changemaker “ COVID’19 Innovation ” - San Diego,USA • Top 50 Innovation Ventures - Bombay StockExchange • Winner of Startup Power2019 • Awarded Most Innovative Startup -NEC www.drnanoxa.com

2. Index Whats your move? www.drnanoxa.com

3. 1 What are we dealingwith? 150 Million + people suffer from microbial infections everyyear • Microbial Infections - Microbes like Bacteria, Viruses and Germs on surfaces leading to infections such as UTI, Coronavirus andothers • Unclean and UnhygienicSurfaces • Healthcare Associated Infections(HAIs) • Frequent intake ofAntibiotics • Ocean Acidification - Inlet of harmful acids, chemicals, and bleaches into water bodies distorting marinelife 195 Countriesaffected 75% of emerging diseasesto human health are viamicrobes $ 9.89 Billion+ spent on Microbial Infectionsannually Solving the pain and agony atsource, thereby reducing the risk on microbial infections viasurfaces ProblemStatement:

4. 3 Origin OfIdea More than 150million people sufferfrom Microbial infection (UTI, Fungal Infections, Coronavirus andothers) Hefty spends on Antibiotics andtreatment + Agony, pain and evendeaths! Why can’t the problem be eliminated at theSource? Can this be combined with ancient knowledge and problem solvingcapability? Can nanotechnology help solve this global problem? (AncientScience+Nanotechnology)

5. 5 We call for local raw material and packaging. We take pride in being vocal aboutlocal Vision &Mission We manufacture locally and are self reliant to meet the demands and supplies of themarket SelfReliant VocalLocal Dr. Nanoxa alignswith Dr. Nanoxa is 100% made in India by Indians forIndians the Swachh Bharat, Swastha BharatMission GoodHealth Sanitation Life BelowWater

7. We have learned about the presence, abundance, and survival of potential pathogens that cause concern for emerging microbial hazards viasurfaces • Dr. Nanoxa is a new age Antimicrobial Surface Coating infused with Nanotechnology which provides bio-security from Bacteria, Viruses and Germs for 30 days* (Applied forPatent) • The 24x7 active contact-killing technology ensures “self-sanitisation” of frequently touched surfaces for prolonged periods of time thus preventing “human-surface-human” transmission ofmicrobes • Eliminates the recurring need/ effort to disinfectsurfaces • Dr. Nanoxa is successfully tested and proven effectiveagainst • SARS - CoV - 2 (Coronavirus) after 45 days livepilot • Click Here : How itWorks *Terms & Conditionsapply.

8. How Dr. Nanoxaworks

9. Antibacterial and Antiviral efficacy>99.9% • 24x7 active contact-killing Antimicrobial SurfaceCoating • Tested and Proven effective againstSARS-CoV-2 • Easy once-a-monthapplication • EPA approvedIngredients • Tested with American and InternationalStandards • Transparent, Skin and Environment FriendlyCoating • Application Methodology : • Clear the surface of debris and make it smooth • Spray Dr. Nanoxa evenly using Sprayers / Rollers by keeping a distance of 25-30 cm (1feet) • Wipe (Buff) the surface with a SOFT cloth (Microfibre) and allow the surface todry Dr. Nanoxa CoatedSurface and manymore...

10. *Parameters are based onsurvey

11. SARS - CoV -2 (Coronavirus) Antiviral : Fabrics 30 Days : 5 Washes AmericanStandards > 99.9% Antiviral : Soiled Ceramic 30 Days : Oil, Paan andUrine InternationalStandards > 99% Antiviral : Coronavirus 45 Days : 5 Star HotelRoom InternationalStandards >99.9% *tested externally by NABL (National Accreditation Board for testing Laboratories - Govt. of IndiaAccredited)

12. The Global Antimicrobial Coatings market size is estimated to be USD 7.1 Billion in 2019 and is projected to grow at a CAGR of 12.8% from 2020 to 2027 • Asia Pacific is expected to witness healthy growth due to developments in the healthcaresegment • Due to COVID19 pandemic, there is an upsurge demand for antimicrobial coatings in variousindustries • Application areas - Public Transport - Railways, Airports, Educational Universities, Commercial Establishments - Malls, Theatres, Healthcare, Hotel Chains, Gyms, Public Places and manymore The approx. addressablemarket in India aloneis 39,500 crore squarefeet 1 Litre of Dr. Nanoxacovers ~ 150 square feet surfacearea Global Antimicrobial Market Share, by end use, 2025(%)

13. MarketSegmentation Transportation Hubs: Railways, Airports, BusDepots Commercial Establishments: Offices, Workplaces, Banksetc B2G Education Institutions: Schools, Colleges, Universities. B2C B2B Homes, Co-living Spacesetc Public utilities: Toilets (Sulabh Souchalaya),Hospitals, Gyms andothers Retail/ Mega Retail: Malls, Theatres, Restaurantsetc

14. *Market size is taken by approximations and assumptions and are 15% ofactuals.

15. Antimicrobial Paints andVarnishes AntimicrobialTextiles andSurgicals Market Size : 127 BillionRupees HVACCoils Market Size : 57 TrillionRupees Market Size : 4.2 BillionRupees

16. OperationalReadiness ManufacturingCapacity: ProductConsumption: • Existing facility having manufacturing capacity of 10K litres per day, Capacity can be increased with time. 1 Ltr of Dr. Nanoxacovers ~500 sq ft surfacearea Packaging facilities alreadyestablished. Packaging available in 1 litre, 5 litre and 20 litrecans. PackagingFacility: UnitEconomy: < INR 0.5 per Sq Ft perday WarehousingFacility: In-house warehousing facility already established.

17. On Click - Social Business ModelCanvas

20. What is Dr. Nanoxa How Dr. Nanoxaworks Test ReportDeck ATP Microbial Load Comparison on varioussurfaces yash@drnanoxa.com For every unit sold, we take complete charge to disinfect 1 toilet in ruralIndia. - Dr. NanoxaTeam www.drnanoxa.com